Meritage Portfolio Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $423K | Sell |
1,473
-57
| -4% | -$16.4K | 0.03% | 262 |
|
|
2025
Q1 | $472K | Buy |
1,530
+84
| +6% | +$25.9K | 0.03% | 247 |
|
|
2024
Q4 | $510K | Buy |
1,446
+157
| +12% | +$55.4K | 0.03% | 244 |
|
|
2024
Q3 | $462K | Buy |
1,289
+113
| +10% | +$40.5K | 0.03% | 263 |
|
|
2024
Q2 | $375K | Sell |
1,176
-1
| -0.1% | -$319 | 0.02% | 266 |
|
|
2024
Q1 | $270K | Sell |
1,177
-69
| -6% | -$15.8K | 0.02% | 307 |
|
|
2023
Q4 | $274K | Buy |
1,246
+21
| +2% | +$4.62K | 0.02% | 308 |
|
|
2023
Q3 | $277K | Sell |
1,225
-41
| -3% | -$9.27K | 0.02% | 295 |
|
|
2023
Q2 | $279K | Buy |
1,266
+207
| +20% | +$45.6K | 0.02% | 303 |
|
|
2023
Q1 | $237K | Sell |
1,059
-36
| -3% | -$8.06K | 0.02% | 285 |
|
|
2022
Q4 | $305K | Buy |
1,095
+37
| +3% | +$10.3K | 0.02% | 255 |
|
|
2022
Q3 | $222K | Buy |
1,058
+6
| +0.6% | +$1.26K | 0.02% | 276 |
|
|
2022
Q2 | $248K | Buy |
+1,052
| New | +$248K | 0.02% | 268 |
|
|
2022
Q1 | – | Sell |
-946
| Closed | -$204K | – | 385 |
|
|
2021
Q4 | $204K | Buy |
+946
| New | +$204K | 0.01% | 328 |
|
|
2017
Q2 | – | Sell |
-37,801
| Closed | -$5.12M | – | 210 |
|
|
2017
Q1 | $5.12M | Buy |
37,801
+502
| +1% | +$68K | 0.54% | 83 |
|
|
2016
Q4 | $5.35M | Sell |
37,299
-419
| -1% | -$60.1K | 0.58% | 72 |
|
|
2016
Q3 | $4.45M | Buy |
+37,718
| New | +$4.45M | 0.49% | 108 |
|
|
2014
Q3 | – | Sell |
-57,557
| Closed | -$5.09M | – | 218 |
|
|
2014
Q2 | $5.09M | Buy |
57,557
+872
| +2% | +$77.2K | 0.55% | 73 |
|
|
2014
Q1 | $5.33M | Buy |
56,685
+815
| +1% | +$76.6K | 0.64% | 56 |
|
|
2013
Q4 | $6.32M | Sell |
55,870
-2,428
| -4% | -$275K | 0.78% | 27 |
|
|
2013
Q3 | $4.6M | Buy |
58,298
+1,845
| +3% | +$145K | 0.6% | 68 |
|
|
2013
Q2 | $3.72M | Buy |
+56,453
| New | +$3.72M | 0.53% | 87 |
|